NCT05962892

Brief Summary

A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative demographic data, ultrasonography, other relevant laboratory tests, and thyroid disease-related scales such as fatigue, depression, and stress were collected. The influencing factors of PTC recurrence were analyzed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Feb 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Feb 2024Feb 2028

First Submitted

Initial submission to the registry

July 19, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2028

Last Updated

January 30, 2024

Status Verified

February 1, 2023

Enrollment Period

4.1 years

First QC Date

July 19, 2023

Last Update Submit

January 29, 2024

Conditions

Papillary Thyroid CarcinomaThermal Ablation

Keywords

Papillary Thyroid CarcinomacohortThermal AblationRecurrence

Outcome Measures

Primary Outcomes (1)

  • the recurrence of PTC

    the recurrence of PTC during follow-up

    1 to 5 years

Study Arms (1)

No Intervention

Other: No Intervention

Interventions

No InterventionOTHER

No Intervention

No Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with pathologically proven PTC underwent ultrasound-guided percutaneous thermal ablation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital

Beijing, China

RECRUITING

MeSH Terms

Conditions

Thyroid Cancer, PapillaryRecurrence

Condition Hierarchy (Ancestors)

Adenocarcinoma, PapillaryAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsThyroid NeoplasmsEndocrine Gland NeoplasmsNeoplasms by SiteHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Xianquan Shi, PhD

CONTACT

18510085125sonoshixq@ccmu.edu.cn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2023

First Posted

July 27, 2023

Study Start

February 1, 2024

Primary Completion (Estimated)

February 28, 2028

Study Completion (Estimated)

February 28, 2028

Last Updated

January 30, 2024

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)